TY  - JOUR
A1  - Müller-von der Grün, Jens
A1  - Martin, Daniel
A1  - Stöver, Timo
A1  - Ghanaati, Shahram Michael
A1  - Rödel, Claus
A1  - Balermpas, Panagiotis
T1  - Chemoradiotherapy as definitive treatment for elderly patients with head and neck cancer
T2  - BioMed research international
N2  - Background: With the aging population and a rising incidence of squamous cell carcinoma of the head and neck (SCCHN), there is an emerging need for developing strategies to treat elderly patients.
Patients and Methods: We retrospectively analyzed 158 patients treated with definitive, concurrent chemoradiotherapy (CRT) for SCCHN. Clinicopathological characteristics, acute toxicities, and oncological outcomes were compared between patients younger and older than (or of age equal to) 65, 70, and 75 years.
Results: RT dose, chemotherapy regimen, and total chemotherapy dose were balanced between the groups. After a median follow-up of 29 months, overall survival (OS), progression-free survival (PFS), local control rate, and distant metastasis-free survival stratified by age of ≥65, ≥70, or ≥75 years revealed no differences. The rate of acute toxicities was also not higher for older patients. Worse ECOG performance score (ECOG 2-3) was associated with impaired OS () and PFS ().
Conclusion: Definitive treatment with CRT for SCCHN is feasible and effective; even in advanced age treatment decisions should be made according to general condition and comorbidity, rather than calendar age alone.
Y1  - 2018
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/46968
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-469684
SN  - 2314-6141
SN  - 2314-6133
N1  - Copyright © 2018 Jens Müller von der Grün et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
VL  - 2018
IS  - Art. 3508795
SP  - 1
EP  - 9
PB  - Hindawi
CY  - New York [u. a.]
ER  -